HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diana E Ayala Selected Research

Chronotherapy

12/2020Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
5/2018Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk.
10/2017Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy.
10/2017Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management.
1/2017Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
5/2016Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.
1/2016[Ambulatory blood pressure, chronotherapy of hypertension and glaucoma].
1/2015Bedtime hypertension chronotherapy: concepts and patient outcomes.
6/2014Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy.
4/20132013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diana E Ayala Research Topics

Disease

46Hypertension (High Blood Pressure)
12/2020 - 06/2003
21Essential Hypertension
08/2011 - 05/2003
10Chronic Renal Insufficiency
12/2020 - 03/2013
8Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 09/2005
6Stroke (Strokes)
05/2018 - 06/2003
6Myocardial Infarction
05/2018 - 06/2003
4Pre-Eclampsia (Preeclampsia)
03/2013 - 03/2003
4Edema (Dropsy)
03/2013 - 01/2007
3Type 2 Diabetes Mellitus (MODY)
12/2020 - 06/2011
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2013 - 03/2013
2Hemorrhagic Stroke
01/2017 - 05/2016
2Masked Hypertension
04/2013 - 04/2013
2Proteinuria
03/2013 - 03/2013
2Obesity
03/2013 - 03/2013
2Obstructive Sleep Apnea
03/2013 - 03/2013
2Fetal Growth Retardation (Intrauterine Growth Retardation)
03/2013 - 01/2003
2Heart Failure
11/2008 - 11/2006
2Renal Insufficiency (Renal Failure)
11/2008 - 11/2006
1Glaucoma
01/2016
1Atherosclerosis
04/2013
1Stillbirth
03/2013
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2013
1Glucose Intolerance
03/2013
1Hypotension (Low Blood Pressure)
03/2013
1Prehypertension
08/2009
1Chronic Kidney Failure (Chronic Renal Failure)
03/2007
1Abdominal Pain (Pain, Abdominal)
11/2006
1Diarrhea
11/2006
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2003

Drug/Important Bio-Agent (IBA)

9Antihypertensive Agents (Antihypertensives)IBA
12/2011 - 03/2004
8Valsartan (Vals)FDA Link
08/2011 - 09/2003
7CreatinineIBA
05/2018 - 03/2013
6AlbuminsIBA
05/2018 - 03/2013
6Glucose (Dextrose)FDA LinkGeneric
02/2016 - 03/2013
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2013 - 03/2003
4CholesterolIBA
03/2013 - 03/2013
4Pharmaceutical PreparationsIBA
04/2010 - 10/2005
3HDL CholesterolIBA
12/2020 - 03/2013
3Uric Acid (Urate)IBA
03/2013 - 03/2013
3Angiotensin IIIBA
08/2009 - 09/2005
3Nifedipine (Adalat)FDA LinkGeneric
08/2009 - 01/2007
2IS 35IBA
04/2013 - 04/2013
2Triglycerides (Triacylglycerol)IBA
03/2013 - 03/2013
21,4-dihydropyridine (dihydropyridine)IBA
03/2013 - 08/2010
2LDL CholesterolIBA
03/2013 - 03/2013
2HDL LipoproteinsIBA
03/2013 - 03/2013
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2013 - 08/2010
2LDL Lipoproteins (beta Lipoproteins)IBA
03/2013 - 03/2013
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2011 - 07/2009
2Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
11/2008 - 11/2006
2Torsemide (Demadex)FDA LinkGeneric
11/2008 - 11/2006
2Drug CombinationsIBA
01/2008 - 03/2006
2Telmisartan (Micardis)FDA Link
10/2007 - 04/2004
2Fibrinogen (Factor I)FDA Link
09/2003 - 06/2003
1Calcium Channels (Calcium Channel)IBA
01/2015
1CI 22IBA
03/2013
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
08/2011
1Amlodipine (Norvasc)FDA LinkGeneric
07/2010
1spiraprilFDA Link
05/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2009
1Ramipril (Altace)FDA LinkGeneric
07/2009
1olmesartanIBA
01/2009
1EnalaprilFDA LinkGeneric
01/2008
1Superoxides (Superoxide)IBA
10/2005
1TabletsIBA
04/2004
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
05/2003

Therapy/Procedure

24Chronotherapy
12/2020 - 09/2005
15Therapeutics
12/2020 - 10/2005
1Aftercare (After-Treatment)
08/2009
1Drug Therapy (Chemotherapy)
03/2007
1Secondary Prevention
09/2005
1Cesarean Section (Caesarean Section)
01/2003